Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 28, 2013
Insider Transaction Report
Form 4
POWER ROBERT N
Director
Transactions
- Award
Common Shares, no par value
2013-05-24+5,022→ 86,128 total
Footnotes (2)
- [F1]Regular annual grant of restricted stock units equal to $375,000 divided by the closing price of registrant common stock on the date prior to grant, which is the third trading day following the annual meeting.
- [F2]This number represents common shares purchased and other equity awards that were previously reported in Table 1.